查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800865

2025 年至 2033 年動脈粥狀硬化斑塊切除設備市場報告（按產品應用、最終用戶和地區）

Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球動脈粥狀硬化斑塊切除器械市場規模達10.224億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到15.245億美元，2025-2033年期間的複合年成長率（CAGR）為4.31%。周邊動脈疾病（PAD）發病率的上升、技術的顯著進步、人口老化加劇、微創手術的出現、醫療基礎設施的完善以及新興經濟體的報銷政策是推動動脈粥狀硬化斑塊切除器械市場成長的一些關鍵因素。

動脈粥狀硬化斑塊切除設備市場趨勢：

周邊動脈疾病（PAD）病例不斷增加

由於人口老化、糖尿病和肥胖症的增多，全球周邊動脈疾病 (PAD) 病例不斷增加，這推動了動脈粥狀硬化斑塊切除器械市場的成長。在美國，周邊動脈疾病 (PAD) 影響約 800 萬至 1,200 萬人，尤其是 50 歲以上的人。其中，40 歲以上的患者約有 650 萬人被診斷出患有周邊動脈疾病 (PAD)。動脈粥狀硬化斑塊切除器械是一種微創方法，可去除動脈斑塊，是血管介入治療的重要替代方案。此器械可增強血流，緩解腿部疼痛和疲勞等症狀。透過直接切除或汽化斑塊，這些器械有助於恢復動脈通暢，顯著改善重度周邊動脈疾病 (PAD) 患者的預後。

技術進步

動脈粥狀硬化斑塊切除術的主要創新包括定向控制裝置和高頻旋轉技術的出現，這些技術不斷提高這些設備的有效性和安全性。例如，2020 年的一項研究表明，軌道式動脈粥狀硬化斑塊切除術（可磨除斑塊）可有效疏通阻塞的腿部動脈，成功率為 90%，而雷射動脈粥樣硬化斑塊切除術可有效改善血流，成功率為 76%。患者預後的改善以及外科醫生對這些設備的偏好正在推動動脈粥狀硬化斑塊切除術設備的發展。在一項針對 172 名患者的多中心研究中，Jetstream 設備的使用成功率為 99%，6 個月和 12 個月的臨床驅動標靶病變血管重建率分別為 15% 和 26%；基於雙功能成像，一年內再狹窄率為 38%。

拓展新興市場

知名的關鍵參與者正聚焦於醫療基礎設施建設和醫療支出不斷成長的新興經濟體，從而為市場關鍵參與者創造新的機會。例如，巴西、俄羅斯、印度、中國和南非（金磚國家）等新興市場正日益塑造全球衛生領域對醫療產品和服務的供需格局。預計2030年醫療支出將佔GDP的比重為：巴西8.4%；俄羅斯5.2%；印度3.5%；中國5.9%；南非10.4%。更先進的治療方案的實現使得這些市場的滲透成為可能，從而擴大了動脈粥狀硬化斑塊切除設備的全球覆蓋範圍。

動脈粥狀硬化斑塊切除設備市場細分：

按產品分類：

  • 定向旋磨裝置
  • 眼眶動脈粥狀硬化斑塊切除裝置
  • 光消融斑塊切除設備
  • 旋磨設備
  • 支援設備

定向動脈粥狀硬化切除術設備佔據大部分市場佔有率

定向動脈粥狀硬化斑塊切除術 (DCC) 設備旨在精準清除阻塞動脈中的動脈粥狀硬化斑塊。這些設備能夠實現精準控制，從而減少血管壁損傷，這對患者的安全和復原至關重要。其能夠治療多種血管大小的複雜病變，深受血管專科醫生的青睞，並推動了該產品細分市場的成長。這些設備在手術過程中能夠收集和清除斑塊，使其脫穎而出，在許多臨床情況下更受青睞。

按應用分類：

  • 周邊血管
  • 心血管
  • 神經血管

周邊血管佔據大部分市場佔有率

由於周邊動脈疾病 (PAD) 的發生率不斷上升，使用動脈粥狀硬化斑塊切除器械治療周邊血管疾病至關重要。此類器械在重建腿部動脈血流方面發揮關鍵作用，有助於緩解疼痛和行動不便等症狀。該領域的需求源自於其微創特性，與傳統手術相比，該手術恢復期短，併發症風險低，從而提高了患者的治療效果和治療效率。

按最終用戶分類：

  • 醫院
  • 門診手術中心
  • 研究實驗室和學術機構

醫院佔大部分市場佔有率

醫院是動脈粥狀硬化斑塊切除術設備的主要用戶，因為這些手術非常複雜，需要先進的基礎設施和訓練有素的醫療保健專業人員。隨著該細分市場的成長，醫院血管手術數量的成長也隨之而來，這得益於對先進技術和醫療服務提供者培訓計畫的投資。醫院能夠提供包括術後護理在內的各類護理，也使其成為市場中的主導力量。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美佔據市場主導地位

該報告還對所有主要市場進行了全面分析，包括北美（美國、加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）以及中東和非洲。報告指出，北美是最大的動脈粥狀硬化切除設備市場。

北美是動脈粥狀硬化斑塊切除術最大的市場，因為該地區心血管疾病盛行率高、醫療保健體系發達且擁有許多關鍵市場參與者。美國是該地區最大的市場，因為其報銷方案優惠、臨床試驗充足，並且政府對先進醫療器材研發給予了大力支持。該地區對新型醫療保健解決方案應用的投入正在推動市場成長。

（請注意，這只是關鍵參與者的部分列表，完整列表在報告中提供。）

  • 動脈粥狀硬化斑塊切除設備市場充滿活力，主要參與者不斷採用不同的策略，以擴大市場佔有率並滿足市場對微創手術替代方案日益成長的需求。其中一個策略是技術導向，即公司在研發方面投入巨資，改善其設備，使其更有效率、更安全。第二種常見策略是建立策略聯盟與合作關係，以支援知識共享和更優的通路。此外，併購也很常見，這使得公司能夠擴大產品組合和地理覆蓋範圍。監管機構的批准在其中發揮著重要作用，因為公司正努力滿足嚴格的規範，以確保其產品在眾多市場的高效性和安全性。

本報告回答的關鍵問題

  • 2024 年全球動脈粥狀硬化切除設備市場規模是多少
  • 2025 年至 2033 年期間全球動脈粥狀硬化切除設備市場的預期成長率是多少
  • COVID-19 對全球動脈粥狀硬化切除設備市場有何影響
  • 推動全球動脈粥狀硬化切除設備市場的關鍵因素有哪些
  • 根據產品類型，全球動脈粥狀硬化切除設備市場如何分類？
  • 根據應用，全球動脈粥狀硬化切除設備市場如何分類
  • 根據最終用戶，全球動脈粥狀硬化切除設備市場如何分類
  • 全球動脈粥狀硬化切除設備市場的主要區域有哪些
  • 全球動脈粥狀硬化切除設備市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球動脈粥狀硬化斑塊切除設備市場規模？ 2025年至2033年期間，全球動脈粥狀硬化斑塊切除設備市場的預期成長率為何？
  • COVID-19 對全球動脈粥狀硬化切除設備市場有何影響？
  • 推動全球動脈粥狀硬化切除設備市場發展的關鍵因素有哪些？
  • 根據產品，全球動脈粥狀硬化切除設備市場是如何分佈的？
  • 根據應用，全球動脈粥狀硬化切除設備市場是如何分佈的？
  • 根據最終用戶，全球動脈粥狀硬化切除設備市場是如何分佈的？
  • 全球動脈粥狀硬化切除設備市場的主要區域有哪些？
  • 全球動脈粥狀硬化切除設備市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球動脈粥狀硬化切除設備市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 定向旋磨裝置
  • 眼眶動脈粥狀硬化斑塊切除裝置
  • 光消融斑塊切除設備
  • 旋磨設備
  • 支援設備

第7章：市場區隔：依應用

  • 周邊血管
  • 心血管
  • 神經血管

第8章：市場區隔：按最終用戶

  • 醫院
  • 門診手術中心
  • 研究實驗室和學術機構

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：SWOT分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Avinger
    • B. Braun Melsungen AG
    • Biomerics
    • Biotronik
    • Boston Scientific Corporation
    • CR Bard (Becton, Dickinson and Company)
    • Cardinal Health Inc.
    • Koninklijke Philips NV
    • Medtronic
    • Minnetronix Inc.
    • Straub Medical AG (Becton, Dickinson and Company)
    • Terumo Corporation
Product Code: SR112025A2766

The global atherectomy devices market size reached USD 1,022.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,524.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.

Atherectomy Devices Market Trends:

Rising Cases of Peripheral Artery Disease (PAD)

The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.

Technological Advancements

Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.

Expansion into Emerging Markets

Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.

Atherectomy Devices Market Segmentation:

Breakup by Product:

  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices

Directional Atherectomy Devices accounts for the majority of the market share

Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.

Breakup by Application:

  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Peripheral Vascular accounts for the majority of the market share

The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Research Laboratories and Academic Institutes

Hospitals accounts for the majority of the market share

Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.

North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.

Key Questions Answered in This Report

  • 1.What was the size of the global atherectomy devices market in 2024?
  • 2.What is the expected growth rate of the global atherectomy devices market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global atherectomy devices market?
  • 4.What are the key factors driving the global atherectomy devices market?
  • 5.What is the breakup of the global atherectomy devices market based on the product?
  • 6.What is the breakup of the global atherectomy devices market based on the application?
  • 7.What is the breakup of the global atherectomy devices market based on the end user?
  • 8.What are the key regions in the global atherectomy devices market?
  • 9.Who are the key players/companies in the global atherectomy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atherectomy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Directional Atherectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Orbital Atherectomy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Photo-Ablative Atherectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Rotational Atherectomy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Support Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Peripheral Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Avinger
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 B. Braun Melsungen AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biomerics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Biotronik
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Boston Scientific Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 C.R. Bard (Becton, Dickinson and Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Cardinal Health Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Medtronic
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Minnetronix Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Straub Medical AG (Becton, Dickinson and Company)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Terumo Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Atherectomy Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Atherectomy Devices Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Atherectomy Devices Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Atherectomy Devices Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Atherectomy Devices Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Atherectomy Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Atherectomy Devices (Directional Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Atherectomy Devices (Directional Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Atherectomy Devices (Support Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Atherectomy Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Atherectomy Devices (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Atherectomy Devices (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Atherectomy Devices (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Atherectomy Devices (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Atherectomy Devices (Neurovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Atherectomy Devices (Neurovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Atherectomy Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Atherectomy Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia Pacific: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia Pacific: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Atherectomy Devices Industry: SWOT Analysis
  • Figure 79: Global: Atherectomy Devices Industry: Value Chain Analysis
  • Figure 80: Global: Atherectomy Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atherectomy Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Atherectomy Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Atherectomy Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Atherectomy Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Atherectomy Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Atherectomy Devices Market: Competitive Structure
  • Table 7: Global: Atherectomy Devices Market: Key Players